These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 24813579)

  • 21. Combination of everolimus with calcineurin inhibitor medication resulted in post-transplant haemolytic uraemic syndrome in lung transplant recipients--a case series.
    Lovric S; Kielstein JT; Kayser D; Bröcker V; Becker JU; Hiss M; Schiffer M; Sommerwerck U; Haller H; Strüber M; Welte T; Gottlieb J
    Nephrol Dial Transplant; 2011 Sep; 26(9):3032-8. PubMed ID: 21310739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variations in presentation of squamous cell carcinoma in situ (Bowen's disease) in immunocompromised patients.
    Drake AL; Walling HW
    J Am Acad Dermatol; 2008 Jul; 59(1):68-71. PubMed ID: 18440666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Swiss clinical practice guidelines for skin cancer in organ transplant recipients].
    Lapointe AK; Hofbauer G; Anliker M; Arnold A; Binet I; Hunger R; Kempf W; Pascual M; Pelloni F; Serra A; Laffitte E
    Rev Med Suisse; 2010 Apr; 6(246):854-9. PubMed ID: 20455382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppression with mammalian target of rapamycin inhibitor and incidence of post-transplant cancer in kidney transplant recipients.
    Opelz G; Unterrainer C; Süsal C; Döhler B
    Nephrol Dial Transplant; 2016 Aug; 31(8):1360-7. PubMed ID: 27190384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients.
    Tenderich G; Fuchs U; Zittermann A; Muckelbauer R; Berthold HK; Koerfer R
    Clin Transplant; 2007; 21(4):536-43. PubMed ID: 17645716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sirolimus and everolimus induced pneumonitis in adult renal allograft recipients: experience in a center.
    Rodríguez-Moreno A; Ridao N; García-Ledesma P; Calvo N; Pérez-Flores I; Marques M; Barrientos A; Sánchez-Fructuoso AI
    Transplant Proc; 2009; 41(6):2163-5. PubMed ID: 19715862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the chemoprevention of non-melanoma skin cancer in high-risk organ transplant recipients.
    Lien MH; Fenske NA; Glass LF
    Semin Oncol; 2012 Apr; 39(2):134-8. PubMed ID: 22484184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre- and posttransplant management of solid organ transplant recipients: risk-adjusted follow-up.
    Shafaeddin Schreve B; Anliker M; Arnold AW; Kempf W; Laffitte E; Lapointe AK; Mainetti C; Pelloni F; Oberholzer P; Serra A; Streit M; Hofbauer GF;
    Curr Probl Dermatol; 2012; 43():57-70. PubMed ID: 22377920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients.
    Kaufmann RA; Oberholzer PA; Cazzaniga S; Hunger RE
    Eur J Dermatol; 2016 Jun; 26(3):265-70. PubMed ID: 26985913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of non-melanoma skin cancer in solid organ transplant recipients.
    Specchio F; Saraceno R; Chimenti S; Nistico S
    Int J Immunopathol Pharmacol; 2014; 27(1):21-4. PubMed ID: 24674675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirolimus and non-melanoma skin cancer prevention after kidney transplantation: a meta-analysis.
    Gu YH; Du JX; Ma ML
    Asian Pac J Cancer Prev; 2012; 13(9):4335-9. PubMed ID: 23167339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?
    Gonzalez-Vilchez F; Vazquez de Prada JA; Paniagua MJ; Gomez-Bueno M; Arizon JM; Almenar L; Roig E; Delgado J; Lambert JL; Perez-Villa F; Sanz-Julve ML; Crespo-Leiro M; Segovia J; Lopez-Granados A; Martinez-Dolz L; Mirabet S; Escribano P; Diaz-Molina B; Farrero M; Blasco T
    Int J Cardiol; 2014 Jan; 171(1):15-23. PubMed ID: 24309084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
    Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
    Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do wound complications or lymphoceles occur more often in solid organ transplant recipients on mTOR inhibitors? A systematic review of randomized controlled trials.
    Pengel LH; Liu LQ; Morris PJ
    Transpl Int; 2011 Dec; 24(12):1216-30. PubMed ID: 21955006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with everolimus is associated with a procoagulant state.
    Baas MC; Gerdes VE; Ten Berge IJ; Heutinck KM; Florquin S; Meijers JC; Bemelman FJ
    Thromb Res; 2013 Aug; 132(2):307-11. PubMed ID: 23906938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Skin Cancer and Related Skin Tumors in High-Risk Kidney and Liver Transplant Recipients in Queensland, Australia.
    Iannacone MR; Sinnya S; Pandeya N; Isbel N; Campbell S; Fawcett J; Soyer PH; Ferguson L; Davis M; Whiteman DC; Green AC;
    J Invest Dermatol; 2016 Jul; 136(7):1382-1386. PubMed ID: 26968258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Melanoma in organ transplant patients].
    Lévêque L; Dalac S; Dompmartin A; Louvet S; Euvrard S; Catteau B; Hazan M; Schollhamer M; Aubin F; Dreno B; Daguin P; Chevrant-Breton J; Frances C; Bismuth MJ; Tanter Y; Lambert D
    Ann Dermatol Venereol; 2000 Feb; 127(2):160-5. PubMed ID: 10739973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
    Zavos G; Karidis NP; Tsourouflis G; Bokos J; Diles K; Sotirchos G; Theodoropoulou E; Kostakis A
    Int J Dermatol; 2011 Dec; 50(12):1496-500. PubMed ID: 21790552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk factors of non melanoma skin cancers in kidney transplant patients].
    Sułowicz J; Wojas-Pelc A; Ignacak E; Betkowska-Prokop A; Kuzniewski M; Sułowicz W
    Przegl Lek; 2014; 71(1):19-25. PubMed ID: 24712264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoplastic skin lesions in Iranian renal transplant recipients: the role of immunosuppressive therapy.
    Zamanian A; Farshchian M
    J Drugs Dermatol; 2007 Jul; 6(7):703-6. PubMed ID: 17763593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.